Indivior PLC (INDV)
USD 11.98
(3.72%)
USD 11.98
(3.72%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2 Million USD | 103.84% |
| 2022 | -52.03 Million USD | -125.38% |
| 2021 | 205 Million USD | 229.94% |
| 2020 | -157.76 Million USD | -213.38% |
| 2019 | 139.14 Million USD | -47.02% |
| 2018 | 262.66 Million USD | 331.14% |
| 2017 | 60.92 Million USD | 90.08% |
| 2016 | 32.05 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -107.21 Million USD | -328.12% |
| 2024 Q3 | 4 Million USD | 103.73% |
| 2024 Q1 | 47 Million USD | -12.96% |
| 2023 Q2 | 39 Million USD | -11.36% |
| 2023 FY | 2 Million USD | 103.84% |
| 2023 Q4 | 54 Million USD | 141.5% |
| 2023 Q1 | 44 Million USD | 123.32% |
| 2023 Q3 | -130.11 Million USD | -433.64% |
| 2022 FY | -52.03 Million USD | -125.38% |
| 2022 Q4 | -188.68 Million USD | -584.8% |
| 2022 Q3 | 38.92 Million USD | -16.43% |
| 2022 Q2 | 46.57 Million USD | 16.0% |
| 2022 Q1 | 40.15 Million USD | 14.38% |
| 2021 FY | 205 Million USD | 229.94% |
| 2021 Q4 | 35.1 Million USD | 0.0% |
| 2020 FY | -157.76 Million USD | -213.38% |
| 2019 FY | 139.14 Million USD | -47.02% |
| 2018 FY | 262.66 Million USD | 331.14% |
| 2017 FY | 60.92 Million USD | 90.08% |
| 2016 FY | 32.05 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 89.35% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | 125.413% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 95.847% |
| Cosmos Health Inc. | -18.54 Million USD | 110.786% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 109.971% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 100.956% |
| Cronos Group Inc. | -73.96 Million USD | 102.704% |
| Incannex Healthcare Limited | -18.45 Million USD | 110.835% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 104.739% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 83.351% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | 146.492% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 144.385% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 144.385% |
| SCYNEXIS, Inc. | 67.04 Million USD | 97.017% |
| Safety Shot Inc | -15.08 Million USD | 113.26% |
| Theratechnologies Inc. | -23.95 Million USD | 108.348% |
| Alpha Teknova, Inc. | -36.78 Million USD | 105.438% |
| Universe Pharmaceuticals INC | -6.16 Million USD | 132.451% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 95.233% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | 141.365% |
| Dynavax Technologies Corporation | -6.38 Million USD | 131.304% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 100.2% |
| Radius Health, Inc. | -25.79 Million USD | 107.755% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | 164.547% |
| Alvotech | -551.73 Million USD | 100.362% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 101.432% |
| SIGA Technologies, Inc. | 68.06 Million USD | 97.062% |
| Shineco, Inc. | -22.44 Million USD | 108.909% |
| Silver Spike Investment Corp. | 7.34 Million USD | 72.752% |
| Journey Medical Corporation | -3.85 Million USD | 151.908% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | 124.5% |
| Embecta Corp. | 70.4 Million USD | 97.159% |
| Harrow Health, Inc. | -24.41 Million USD | 108.193% |
| Procaps Group, S.A. | 42.54 Million USD | 95.299% |
| Biofrontera Inc. | -20.13 Million USD | 109.935% |
| DURECT Corporation | -27.62 Million USD | 107.24% |
| PainReform Ltd. | -9.34 Million USD | 121.404% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | -51.976% |
| OptiNose, Inc. | -35.48 Million USD | 105.637% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 91.637% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 59.555% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | 131.851% |
| ProPhase Labs, Inc. | -16.78 Million USD | 111.918% |
| Phibro Animal Health Corporation | 2.41 Million USD | 17.219% |
| Procaps Group S.A. | 42.54 Million USD | 95.299% |
| TherapeuticsMD, Inc. | -10.27 Million USD | 119.459% |
| Viatris Inc. | 54.7 Million USD | 96.344% |
| Rockwell Medical, Inc. | -8.43 Million USD | 123.699% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 112.623% |
| Tilray Brands, Inc. | -244.98 Million USD | 100.816% |
| PetIQ, Inc. | 2.13 Million USD | 6.147% |
| Talphera, Inc. | -18.39 Million USD | 110.871% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 99.199% |
| Alimera Sciences, Inc. | -20.13 Million USD | 109.934% |
| Assertio Holdings, Inc. | -331.94 Million USD | 100.603% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | 130.336% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 101.248% |
| Hempacco Co., Inc. | -13.12 Million USD | 115.237% |
| Alvotech | -551.73 Million USD | 100.362% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 99.388% |
| Kamada Ltd. | 8.28 Million USD | 75.857% |
| Currenc Group, Inc. | -15.3 Million USD | 113.066% |
| Evoke Pharma, Inc. | -7.79 Million USD | 125.666% |
| Flora Growth Corp. | -57.03 Million USD | 103.507% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 109.971% |
| Evolus, Inc. | -61.68 Million USD | 103.242% |
| HUTCHMED (China) Limited | 100.78 Million USD | 98.015% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 98.546% |
| Akanda Corp. | -32.27 Million USD | 106.197% |